Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CLSD - Clearside outlines pivotal Phase 3 plans for CLS-AX in wet AMD

CLSD - Clearside outlines pivotal Phase 3 plans for CLS-AX in wet AMD

March, 27 2025 08:31 PM Clearside Biomedical Inc.

2025-03-27 20:31:43 ET

More on Clearside Biomedical

Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call Transcript
Clearside Biomedical GAAP EPS of -$0.10 in-line, revenue of $0.3M beats by $0.01M
Seeking Alpha’s Quant Rating on Clearside Biomedical
Historical earnings data for Clearside Biomedical
Financial information for Clearside Biomedical

For further details see:

Clearside outlines pivotal Phase 3 plans for CLS-AX in wet AMD

Stock Information

Company Name:	Clearside Biomedical Inc.
Stock Symbol:	CLSD
Market:	NASDAQ
Website:	clearsidebio.com

Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.